Franklin M Berger - Net Worth and Insider Trading

Franklin M Berger Net Worth

The estimated net worth of Franklin M Berger is at least $43 Million dollars as of 2024-12-25. Franklin M Berger is the Director of Seagen Inc and owns about 163,720 shares of Seagen Inc (SGEN) stock worth over $37 Million. Franklin M Berger is the Director of Atea Pharmaceuticals Inc and owns about 451,897 shares of Atea Pharmaceuticals Inc (AVIR) stock worth over $1 Million. Franklin M Berger is also the Director of ESSA Pharma Inc and owns about 784,404 shares of ESSA Pharma Inc (EPIX) stock worth over $1 Million. Besides these, Franklin M Berger also holds Rain Oncology Inc (RAIN) , Kezar Life Sciences Inc (KZR) , Immune Design Corp (IMDZ) , Five Prime Therapeutics Inc (FPRX) , Proteostasis Therapeutics Inc (PTI) , Lineage Cell Therapeutics Inc (LCTX) . Details can be seen in Franklin M Berger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Franklin M Berger has not made any transactions after 2024-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Franklin M Berger

To

Franklin M Berger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Franklin M Berger owns 15 companies in total, including ESSA Pharma Inc (EPIX) , Proteostasis Therapeutics Inc (PTI) , and Kezar Life Sciences Inc (KZR) among others .

Click here to see the complete history of Franklin M Berger’s form 4 insider trades.

Insider Ownership Summary of Franklin M Berger

Ticker Comapny Transaction Date Type of Owner
EPIX ESSA Pharma Inc 2023-11-21 director
PTI Proteostasis Therapeutics Inc 2020-06-29 director
KZR Kezar Life Sciences Inc 2022-03-21 director
LIMIT LIMIT 2019-06-19 director
LIMIT LIMIT 2020-05-14 director
LIMIT LIMIT 2017-04-12 director
LIMIT LIMIT 2019-04-02 director
LIMIT LIMIT 2011-06-22 director
LIMIT LIMIT 2013-09-27 director
LIMIT LIMIT 2013-08-20 director
LIMIT LIMIT 2009-05-15 director
LIMIT LIMIT 2016-02-10 director
LIMIT LIMIT 2024-12-10 director
LIMIT LIMIT 2022-11-22 director
LIMIT LIMIT 2016-02-10 director

Franklin M Berger Latest Holdings Summary

Franklin M Berger currently owns a total of 9 stocks. Among these stocks, Franklin M Berger owns 163,720 shares of Seagen Inc (SGEN) as of June 22, 2011, with a value of $37 Million and a weighting of 87.85%. Franklin M Berger owns 451,897 shares of Atea Pharmaceuticals Inc (AVIR) as of December 10, 2024, with a value of $1 Million and a weighting of 3.45%. Franklin M Berger also owns 784,404 shares of ESSA Pharma Inc (EPIX) as of November 21, 2023, with a value of $1 Million and a weighting of 2.96%. The other 6 stocks Rain Oncology Inc (RAIN) , Kezar Life Sciences Inc (KZR) , Immune Design Corp (IMDZ) , Five Prime Therapeutics Inc (FPRX) , Proteostasis Therapeutics Inc (PTI) , Lineage Cell Therapeutics Inc (LCTX) have a combined weighting of 5.74% among all his current holdings.

Latest Holdings of Franklin M Berger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGEN Seagen Inc 2011-06-22 163,720 228.74 37,449,313
AVIR Atea Pharmaceuticals Inc 2024-12-10 451,897 3.25 1,468,665
EPIX ESSA Pharma Inc 2023-11-21 784,404 1.61 1,262,890
RAIN Rain Oncology Inc 2022-11-22 1,005,207 1.21 1,216,300
KZR Kezar Life Sciences Inc 2022-03-21 89,069 6.56 584,293
IMDZ Immune Design Corp 2017-10-30 75,000 5.85 438,750
FPRX Five Prime Therapeutics Inc 2019-12-03 5,000 38.00 190,000
PTI Proteostasis Therapeutics Inc 2018-10-26 15,308 1.11 16,992
LCTX Lineage Cell Therapeutics Inc 2013-08-20 500 0.54 269

Holding Weightings of Franklin M Berger


Franklin M Berger Form 4 Trading Tracker

According to the SEC Form 4 filings, Franklin M Berger has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the acquisition of 7,000 shares on June 22, 2011, which cost Franklin M Berger around $140,280.

According to the SEC Form 4 filings, Franklin M Berger has made a total of 3 transactions in Atea Pharmaceuticals Inc (AVIR) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Atea Pharmaceuticals Inc is the sale of 359,606 shares on December 10, 2024, which brought Franklin M Berger around $1 Million.

According to the SEC Form 4 filings, Franklin M Berger has made a total of 3 transactions in ESSA Pharma Inc (EPIX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in ESSA Pharma Inc is the acquisition of 23,259 shares on November 21, 2023, which cost Franklin M Berger around $133,274.

More details on Franklin M Berger's insider transactions can be found in the Insider Trading History of Franklin M Berger table.

Insider Trading History of Franklin M Berger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Franklin M Berger Trading Performance

GuruFocus tracks the stock performance after each of Franklin M Berger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Franklin M Berger is 19.4%. GuruFocus also compares Franklin M Berger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Franklin M Berger within 3 months outperforms 13 times out of 26 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Franklin M Berger's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Franklin M Berger

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
8 out of 26 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.57 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.64 LIMIT LIMIT LIMIT LIMIT LIMIT

Franklin M Berger Ownership Network

Ownership Network List of Franklin M Berger

No Data

Ownership Network Relation of Franklin M Berger

Insider Network Chart

Franklin M Berger Owned Company Details

What does ESSA Pharma Inc do?

Who are the key executives at ESSA Pharma Inc?

Franklin M Berger is the director of ESSA Pharma Inc. Other key executives at ESSA Pharma Inc include 10 percent owner Biotech Growth N V , Chief Operating Officer Peter Virsik , and director & Chief Executive Officer David Ross Parkinson .

ESSA Pharma Inc (EPIX) Insider Trades Summary

Over the past 18 months, Franklin M Berger made 2 insider transaction in ESSA Pharma Inc (EPIX) with a net purchase of 99,730. Other recent insider transactions involving ESSA Pharma Inc (EPIX) include a net sale of 81,945 shares made by Peter Virsik , a net sale of 7,879,583 shares made by Biotech Growth N V , and a net purchase of 9,223 shares made by David Ross Parkinson .

In summary, during the past 3 months, insiders sold 7,880,277 shares of ESSA Pharma Inc (EPIX) in total and bought 0 shares, with a net sale of 7,880,277 shares. During the past 18 months, 7,961,528 shares of ESSA Pharma Inc (EPIX) were sold and 108,953 shares were bought by its insiders, resulting in a net sale of 7,852,575 shares.

ESSA Pharma Inc (EPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ESSA Pharma Inc Insider Transactions

No Available Data

Franklin M Berger Mailing Address

Above is the net worth, insider trading, and ownership report for Franklin M Berger. You might contact Franklin M Berger via mailing address: 1000 Marina Blvd, Ste 200, Brisbane Ca 94005.

Discussions on Franklin M Berger

No discussions yet.